Inverness Medical Innovations Announces Third Quarter 20...($(0.60)(l) $1....),Health

Date:10/27/2009

$(0.60)(l) $1.30(n) Weighted average common shares - basic 77,630 77,630 Weighted average common shares - diluted 77,630(l) 83,390(n)

(a) In calculating net income or loss on an adjusted cash basis, the Company excludes from net income or loss (i) certain non-cash charges, including amortization expense and stock-based compensation expense, (ii) non-recurring charges and income, and (iii) certain other charges and income that have a significant positive or negative impact on results yet do not occur on a consistent or regular basis in its business. In determining whether a particular item meets one of these criteria, management considers facts and circumstances that it believes are relevant. Management believes that excluding such charges and income from net income or loss allows investors and management to evaluate and compare the Company's operating results from continuing operations from period to period in a meaningful and consistent manner. Due to the frequency of their occurrence in its business, the Company does not adjust net income or loss for the costs associated with litigation, including payments made or received through settlements. It should be noted that "net income or loss on an adjusted cash basis" is not a standard financial measurement under accounting principles generally accepted in the United States of America ("GAAP") and should not be considered as an alternative to net income or loss or cash flow from operating activities, as a measure of liquidity or as an indicator of operating performance or any measure of performance derived in accordance with GAAP. In addition, all companies do not calculate non-GAAP financial measures in the same manner and, accordingly, "net income or loss on an adjusted cash basis" presented in this press release may not be comparable to similar
'/>"/>

SOURCE Inverness Medical Innovations, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17
Related medicine technology :

1. Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimers Disease
2. Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
3. Inverness Medical Innovations Receives USDA Licensure of the BinaxNOW(R) Avian Influenza Virus Type A Antigen Test Kit
4. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
5. StatSure Signs Strategic Financing and License Deals with Inverness Medical Innovations
6. Medical Food Reduces Medical Costs and Use of Anticonvulsant Medication When Treating Diabetic Neuropathy, According to HealthCore Study Presented at ISPOR
7. Reportlinker Adds Medical Devices & Equipment in India (2009)
8. ATS Medical Announces Third Quarter 2009 Earnings Release Date and Conference Call
9. Rcadia Medical Imaging Wins 2009 AuntMinnie.com Best New Radiology Vendor Award
10. Cardio Vascular Medical Device Sends Update to Shareholders
11. Symmetry Medical Updates Full Year 2009 Financial Guidance